ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

Moffitt To Enhance Information For Brain Tumor Patients.

July 13, 2001

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980

Cancer Centers Could Form Network for Genetics Research, NCI Says

April 12, 1996

Four NCAB Appointments Announced, Including Durant, Fisher; White House Delays On Others

April 4, 1986